Filipino
English French German Portuguese Spanish Russian Japanese Korean Arabic Irish Greek Turkish Italian Danish Romanian Indonesian Czech Afrikaans Swedish Polish Basque Catalan Esperanto Hindi Lao Albanian Amharic Armenian Azerbaijani Belarusian Bengali Bosnian Bulgarian Cebuano Chichewa Corsican Croatian Dutch Estonian Filipino Finnish Frisian Galician Georgian Gujarati Haitian Hausa Hawaiian Hebrew Hmong Hungarian Icelandic Igbo Javanese Kannada Kazakh Khmer Kurdish Kyrgyz Latin Latvian Lithuanian Luxembou.. Macedonian Malagasy Malay Malayalam Maltese Maori Marathi Mongolian Burmese Nepali Norwegian Pashto Persian Punjabi Serbian Sesotho Sinhala Slovak Slovenian Somali Samoan Scots Gaelic Shona Sindhi Sundanese Swahili Tajik Tamil Telugu Thai Ukrainian Urdu Uzbek Vietnamese Welsh Xhosa Yiddish Yoruba Zulu Kinyarwanda Tatar Oriya Turkmen Uyghur
Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write

Wang Liang

Pamagat：Punong Manggagamot
Posisyon：Punong Dibisyon
Personal na Profile：Punong Manggagamot, Propesor, Ph.D. Superbisor, kasalukuyang Direktor ng Hematology Department ng Peking Tongren Hospital. Nagtapos siya sa Peking Union Medical College noong 2010, na nag-major sa Clinical Medicine sa walong-taong sistema, at nakakuha ng Doctor of Medicine degree. Mahigit 10 taon na siyang nakikibahagi sa diagnosis at paggamot ng mga hematologic tumor (lymphoma, multiple myeloma, atbp.), at may mayamang klinikal na karanasan at mataas na akademikong tagumpay sa diagnosis at paggamot ng iba't ibang uri ng lymphoma at myelomas, at dalubhasa sa targeted immunotherapy, chemotherapy, CAR-T cell therapy, hematopoietic stem cell transplantation, at nangunguna sa pag-unlad ng multidisciplinary diagnosis and treatment (MDT). Ang kanyang pangunahing interes sa pananaliksik ay ang targeted immunotherapy at drug resistance mechanism exploration ng lymphoma, at pinamunuan niya ang ilang National Natural Science Foundation of China. Nakapaglathala na siya ng mahigit 40 propesyonal na papel, kabilang ang mahigit 30 papel na may indeks na SCI, na nailathala na sa Lancet Haematology, Journal of Hematology & Oncology, Leukemia, Clinical Cancer Research, Cancer Treatment Reviews, Cancer Therapy Reviews, at iba pang mga journal at journal. Nakapaglathala na rin siya sa Lancet Haematology, Journal of Hematology & Oncology, Leukemia, Clinical Cancer Research, Cancer Treatment Reviews, Cancer, British Journal of Cancer, Annals of Hematology, at Leukemia & Lymphoma. Siya ang co-editor ng Standard Leukemia Diagnosis and Treatment, Standard Multiple Myeloma Diagnosis and Treatment, at Medical Oncology. Ginawaran siya ng “Respect for Life-2017 Glory to Healers-Youth Innovation Award”, “Tongren Elite” award noong 2020, “Tongren Hospital Outstanding Young Talent” award noong 2020, at ang unang “Tongren Hospital Outstanding Young Talent” award noong 2020. Tongren Hospital Outstanding Young Talent” noong 2020, '35 Young Oncologists Under 35 with the Most Potential in China'. Mga Kaugnayan sa Akademiko: Batang Miyembro ng Hematology Branch ng Chinese Medical Association; Nananatiling Miyembro ng Lymphoma Immunotherapy Committee ng Beijing Cancer Prevention and Control Society; Nananatiling Miyembro ng Myeloma Committee ng China Medical Education Association; Dalubhasa ng National Natural Science Foundation of China. Siya ay isang associate editor ng Aging Pathobiology and Therapeutics, isang miyembro ng editorial board ng Chinese Journal of Cancer Prevention and Control, isang batang miyembro ng editorial board ng Concord Medical Journal, at isang tagasuri ng Journal of Hematology & Oncology at Cancer Biology & Medicine.

Wang Liang